PFBT
NKTR icon

Parkside Financial Bank & Trust’s Nektar Therapeutics NKTR Stock Holding History

Parkside Financial Bank & Trust’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-52
Closed -$3.74K – 2765
2026
Q1 		$3.74K Buy
+52
New +$2.96K ﹤0.01% 1914
2022
Q4 		– Sell
-10
Closed – – 2034
2022
Q3 		$0 Sell
10
-91
-90% -$5.41K ﹤0.01% 1893
2022
Q2 		$6K Buy
101
+32
+46% +$2.02K ﹤0.01% 1177
2022
Q1 		$6K Buy
69
+12
+21% +$1.78K ﹤0.01% 1231
2021
Q4 		$12K Buy
57
+56
+5,600% +$12.1K ﹤0.01% 966
2021
Q3 		$0 Sell
1
-3
-75% -$721 ﹤0.01% 1818
2021
Q2 		$1K Buy
4
+1
+33% +$277 ﹤0.01% 1646
2021
Q1 		$1K Buy
+3
New +$934 ﹤0.01% 1622
2020
Q4 		– Sell
-3
Closed -$1K – 1649
2020
Q3 		$1K Sell
3
-1
-25% -$315 ﹤0.01% 1383
2020
Q2 		$1K Sell
4
-2
-33% -$624 ﹤0.01% 1348
2020
Q1 		$1K Buy
6
+4
+200% +$1.24K ﹤0.01% 1294
2019
Q4 		$1K Sell
2
-1
-33% -$290 ﹤0.01% 1435
2019
Q3 		$1K Sell
3
-1
-25% -$367 ﹤0.01% 1401
2019
Q2 		$2K Buy
4
+1
+33% +$501 ﹤0.01% 1194
2019
Q1 		$2K Buy
3
+1
+50% +$593 ﹤0.01% 1184
2018
Q4 		$1K Buy
2
+1
+100% +$604 ﹤0.01% 1264
2018
Q3 		$1K Hold
1
– – ﹤0.01% 1320
2018
Q2 		$1K Hold
1
– – ﹤0.01% 1303
2018
Q1 		$2K Sell
1
-5
-83% -$6.44K ﹤0.01% 1034
2017
Q4 		$5K Hold
6
– – ﹤0.01% 857
2017
Q3 		$2K Hold
6
– – ﹤0.01% 993
2017
Q2 		$2K Hold
6
– – ﹤0.01% 1001
2017
Q1 		$2K Hold
6
– – ﹤0.01% 982
2016
Q4 		$1K Buy
+6
New +$1.22K ﹤0.01% 1159

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parkside Financial Bank & Trust's NKTR Position: Q2 2026 in Review

Parkside Financial Bank & Trust sold out of Nektar Therapeutics (NKTR) in Q2 2026, closing a stake of 52 shares — an estimated $3.74K sold.

Parkside Financial Bank & Trust first reported a position in NKTR in Q4 2016 and held it in 24 quarters. The position peaked at $12K in Q4 2021. 239 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.

  • Parkside Financial Bank & Trust reported no remaining Nektar Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 52 Nektar Therapeutics shares in Q2 2026, an estimated $3.74K.
  • Parkside Financial Bank & Trust first reported a position in Nektar Therapeutics in Q4 2016 and held it in 24 quarters.
  • Parkside Financial Bank & Trust's Nektar Therapeutics position peaked at $12K in Q4 2021.
  • 239 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.